Our findings revealed that the pharmacological suppression of PD-L1 or the PI3K-AKT-mTOR pathway, alone (Fig. 7a, b) or in combination (Fig. 7c), significantly suppressed the formation and expansion of organoids derived from AM patients. Here, AKT1 is linked to acute myeloblastic leukemia with maturation.